SCHEDULE: Saba Capital Discloses 10.46% Stake in Sharps Technology

Saba Capital Management, L.P. and affiliates have disclosed a 10.46% beneficial ownership stake in Sharps Technology, Inc., primarily through common stock and warrants.

Summary

• Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein (collectively, the "Reporting Persons") have filed an Amendment No. 2 to Schedule 13G.
• The Reporting Persons beneficially own an aggregate of 3,195,097 shares of Sharps Technology, Inc. Common Stock and Warrants.
• This ownership represents 10.46% of the class of securities.
• The percentage is calculated based on 28,995,402 shares outstanding as of December 15, 2025, plus 1,538,462 shares issuable upon the exercise of certain warrants held by the Reporting Persons.
• The event requiring this filing occurred on January 9, 2026.
• The Reporting Persons have shared voting and dispositive power over all 3,195,097 shares.
• The securities were not acquired for the purpose of changing or influencing control of the issuer, nor in connection with any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.

Sentiment

Score: 5

Explanation: The filing is a factual disclosure of beneficial ownership, which is neutral in sentiment. The statement that the stake is not for control influence is a positive clarification, but the overall nature of the document is informational rather than evaluative of company performance.

Positives

• A significant stake by an institutional investor like Saba Capital can signal confidence in the company's long-term prospects.
• The filing explicitly states the stake is not for changing or influencing control, which may reduce concerns about activist investor pressure for immediate, potentially disruptive, changes.

Negatives

• No explicit negatives are present in this beneficial ownership disclosure.

Risks

• The filing indicates the possibility of activities solely in connection with a nomination under Rule 14a-11, which could imply future engagement in proxy contests or board nominations, potentially leading to management or strategic changes.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding Sharps Technology, Inc.'s future outlook.

Industry Context

Saba Capital Management, L.P. is a prominent investment adviser known for its event-driven strategies, often taking significant stakes in companies. Their disclosure of a substantial position in Sharps Technology, Inc. indicates their interest in the medical technology or healthcare sector, where Sharps Technology operates with its safety syringe technology.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional investor's stake could be viewed positively, potentially increasing investor confidence and liquidity. The explicit statement against seeking control may reassure existing management and board.
• Management: The filing clarifies that the stake is not for influencing control, which may alleviate immediate concerns about activist pressure, though potential future nominations under Rule 14a-11 are noted.

Key Dates

Keywords

Sharps Technology, Saba Capital Management, Boaz R. Weinstein, Beneficial Ownership, Schedule 13G, Common Stock, Warrants, Institutional Investor, Stake, SEC Filing